Abstract

Objective The prognostic impact of right ventricular systolic dysfunction (RVSD) in heart failure (HF) with preserved ejection fraction (HFPEF) is not suffi ciently understood. This pilot study evaluates the prevalence and prognostic impact of RVSD in HFPEF.Methods Ninety-fi ve consecutive patients, admitted due to HF within one year were included and followed up for 12 months. Patients were classifi ed based on left ventricular ejection fraction (LVEF) into two groups: HFPEF (LVEF > 40%; n = 54), and heart failure with reduced ejection fraction (HFREF) (LVEF ≤ 40%; n = 41). RVSD was defi ned as peak systolic tricuspid annular velocity (S’) < 10.8 cm/s. Results The prevalence of RVSD was 22% vs 59%, in HFPEF vs HFREF, respectively (P < 0.001). Patients with HFPEF and RVSD had signifi cantly higher one-year all-cause mortality compared to HFPEF with normal RV function (41.7% vs 4.8%, P = 0.004). The same trend was found in HFREF (33.3% vs 5.9%, P = 0.057). A similar outcome was observed in cardiovascular mortality (HFPEF 33.3% vs 0%, P = 0.002 and HFREF 20.8% vs 0%, P = 0.06). RVSD was the only independent predictor of all-cause one-year mortality in patients with HFPEF (HR 11.5, 95% CI 2.2 to 59.5, P = 0.004).Conclusion RVSD is an independent predictor of all-cause mortality in HFPEF. Patients with HFPEF and RVSD had signifi cantly higher one-year all-cause and cardiovascular mortality than those with normal RV function.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.